首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Caulis Lonicerae Japonicae extract shows protective effect on osteoporosis in rats
【24h】

Caulis Lonicerae Japonicae extract shows protective effect on osteoporosis in rats

机译:金银花提取物对大鼠骨质疏松有保护作用

获取原文
       

摘要

Purpose: To investigate the effect of Caulis lonicerae Japonicae extract (CLJE) on ovariectomy-induced osteoporosis in rats. Methods: Female Sprague-Dawley rats were randomly assigned to a control group (normal rats) and five ovariectomy (OVX) subgroups: OVX with vehicle (OVX), OVX with 17?-estradiol (E2, 25μg/kg/day), and OVX with CLJE doses (150, 300, and 600 mg/kg/day). Daily oral administration of E2 or CLJE started 4 weeks after OVX and lasted for 16 weeks. The bone mineral density (BMD) of L4 vertebrae and right femurs was determined. The length of each femur was measured with a micrometer, and the center of the diaphysis was determined. Three representative L4 vertebrae were selected to evaluate trabecular microarchitecture. Serum alkaline phosphatase (ALP), urinary calcium (U-Ca), urinary phosphorus (U-P), urinary creatinine (Cr) and osteocalcin (OC) levels were measured using a diagnostic reagent kit. Result: The results show that a high-dose of CLJE (600 mg/kg) significantly inhibited bone mineral density (BMD) reduction of L4 vertebrae (0.24 ± 0.02, p 0.05) and femur (0.24 ± 0.03, p 0.05) caused by OVX, and prevented the deterioration of trabecular microarchitecture (p 0.05). High-dose CLJE also improved morphometric parameters, viz, trabecular number (Tb-N) (4.6 ± 0.3, p 0.05), trabecular thickness (Tb-Th, 0.084 ± 0.012, p 0.05) and trabecular separation (Tb-Sp, 0.14 ± 0.02, p 0.05) in L4 vertebrae significantly. Conclusion: The results indicate that CLJE prevents OVX-induced osteoporosis in rats. Thus, CLJE is a potential natural alternative for the treatment of postmenopausal osteoporosis in future.
机译:目的:研究金银花提取物(CLJE)对卵巢切除术引起的大鼠骨质疏松的影响。方法:将雌性Sprague-Dawley大鼠随机分为对照组(正常大鼠)和5个卵巢切除术(OVX)亚组:OVX配载体(OVX),OVX配17α-雌二醇(E2,25μg/ kg / day),以及含CLJE剂量的OVX(150、300和600 mg / kg /天)。 OVX后4周开始每日口服E2或CLJE,持续16周。确定L4椎骨和右股骨的骨矿物质密度(BMD)。用千分尺测量每个股骨的长度,并确定骨干的中心。选择了三个代表性的L4椎骨来评估小梁微结构。使用诊断试剂盒测量血清碱性磷酸酶(ALP),尿钙(U-Ca),尿磷(U-P),尿肌酐(Cr)和骨钙蛋白(OC)的水平。结果:结果表明,大剂量的CLJE(600 mg / kg)显着抑制L4椎骨(0.24±0.02,p <0.05)和股骨(0.24±0.03,p <0.05)的骨矿物质密度(BMD)降低。由OVX引起,并防止了小梁微结构的恶化(p <0.05)。大剂量CLJE还改善了形态学参数,即,小梁数目(Tb-N)(4.6±0.3,p <0.05),小梁厚度(Tb-Th,0.084±0.012,p <0.05)和小梁分离(Tb-Sp ,在L4椎骨中显着(0.14±0.02,p <0.05)。结论:结果表明,CLJE可以预防OVX诱导的大鼠骨质疏松。因此,CLJE是将来治疗绝经后骨质疏松症的潜在天然替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号